Literature DB >> 3056477

Benefits of dual chamber pacing in sick sinus syndrome.

T Mitsuoka1, R A Kenny, T A Yeung, S L Chan, J E Perrins, R Sutton.   

Abstract

The effects of DDD (fully automatic) and VVI (ventricular demand) pacing modes on exercise tolerance, symptom diary cards, and Holter monitoring were investigated in a randomised double blind crossover study of 16 patients who had had DDD pacemakers implanted because of frequent syncope. Eight patients presented with sick sinus syndrome and, with one exception, retrograde atrioventricular conduction and eight age and sex matched patients presented with 2:1 or complete atrioventricular block. Maximal symptom limited exercise in those with atrioventricular block was significantly higher after one month of DDD pacing than after VVI pacing. In those with sick sinus syndrome, however, maximal effort tolerance was not significantly different for the two pacing modes. In all but one patient with sick sinus syndrome sinus rhythm developed during exercise in VVI pacing. For both VVI and DDD modes maximal atrial rates were significantly lower in those with sick sinus syndrome. Palpitation and general wellbeing were significantly improved during DDD pacing in the eight patients with sick sinus syndrome. Shortness of breath was improved by DDD pacing in the eight patients with atrioventricular block but not in those with sick sinus syndrome. Holter monitoring showed that sick sinus syndrome patients remained in paced rhythm, either DDD or VVI, for most of the 24 hour period. DDD pacing was better than VVI pacing in sick sinus syndrome with retrograde atrioventricular conduction. Despite their ability to show sinus rhythm and inhibit their pacemakers on exercise patients with sick sinus syndrome are just as likely to have symptomatic benefit from DDD pacing as patients with atrioventricular block.

Entities:  

Mesh:

Year:  1988        PMID: 3056477      PMCID: PMC1216582          DOI: 10.1136/hrt.60.4.338

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  24 in total

1.  Clinical use of a new transvenous atrial lead.

Authors:  M Kleinert; M Bock; F Wilhemi
Journal:  Am J Cardiol       Date:  1977-08       Impact factor: 2.778

2.  Cardiac pacing and pacemakers VI. Analysis of pacemaker malfunction.

Authors:  S Furman
Journal:  Am Heart J       Date:  1977-09       Impact factor: 4.749

3.  Clinical and electrophysiological characteristics of a transvenous atrial lead.

Authors:  I Kruse; L Rydén; B Ydse
Journal:  Br Heart J       Date:  1979-11

4.  Atrial fibrillation during A-V sequential pacing.

Authors:  S Furman; J A Cooper
Journal:  Pacing Clin Electrophysiol       Date:  1982-01       Impact factor: 1.976

5.  Epidemiologic features of chronic atrial fibrillation: the Framingham study.

Authors:  W B Kannel; R D Abbott; D D Savage; P M McNamara
Journal:  N Engl J Med       Date:  1982-04-29       Impact factor: 91.245

6.  Dual chamber sequential pacing management of sinus node dysfunction: advantages over single-chamber pacing.

Authors:  J M Stone; R D Bhakta; J Lutgen
Journal:  Am Heart J       Date:  1982-12       Impact factor: 4.749

7.  Atrioventricular and ventriculo-atrial conduction in patients with symptomatic sinus node dysfunction.

Authors:  R van Mechelen; F Hagemeijer; H de Boer; A Schelling
Journal:  Pacing Clin Electrophysiol       Date:  1983-01       Impact factor: 1.976

8.  Hemodynamic and symptomatic consequences of ventricular pacing.

Authors:  R A Nishimura; B J Gersh; R E Vlietstra; M J Osborn; D M Ilstrup; D R Holmes
Journal:  Pacing Clin Electrophysiol       Date:  1982-11       Impact factor: 1.976

9.  Characterisation of heart rate response to exercise in the sick sinus syndrome.

Authors:  W Holden; J H McAnulty; S H Rahimtoola
Journal:  Br Heart J       Date:  1978-08

10.  Hemodynamic compromise associated with ventriculoatrial conduction following transvenous pacemaker placement.

Authors:  A D Johnson; S L Laiken; R L Engler
Journal:  Am J Med       Date:  1978-07       Impact factor: 4.965

View more
  6 in total

1.  Recommendations for pacemaker prescription for symptomatic bradycardia. Report of a working party of the British Pacing and Electrophysiology Group.

Authors: 
Journal:  Br Heart J       Date:  1991-08

2.  Recommendations for pacing.

Authors:  K M Channon; T R Cripps; O Ormerod
Journal:  BMJ       Date:  1992-12-05

3.  "Subclinical" pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices.

Authors:  N Sulke; A Dritsas; J Bostock; A Wells; R Morris; E Sowton
Journal:  Br Heart J       Date:  1992-01

4.  Double blind crossover comparison of the effects of dual chamber pacing (DDD) and ventricular rate adaptive (VVIR) pacing on neuroendocrine variables, exercise performance, and symptoms in complete heart block.

Authors:  K G Oldroyd; A P Rae; R Carter; C Wingate; S M Cobbe
Journal:  Br Heart J       Date:  1991-04

5.  Atrial fibrillation in patients with permanent VVI pacemakers: risk factors for atrial fibrillation.

Authors:  J G Cho; Y H Jeong; I J Cho; Y G Ahn; K S Cha; J P Seo; J H Park; M H Jeong; J C Park; J C Kang
Journal:  Korean J Intern Med       Date:  1997-01       Impact factor: 2.884

Review 6.  Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block.

Authors:  J Dretzke; W D Toff; G Y H Lip; J Raftery; A Fry-Smith; R Taylor
Journal:  Cochrane Database Syst Rev       Date:  2004
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.